维普期刊资源整合服务平台（V6.5）

84篇 您的检索式：作者名="Costa DB"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib显示文摘	COSTA DB NGUYEN KS CHO BC	2008	Clin Cancer Res2008，14，21：	1
2	BIM mediates EGFR tyro- sine kinase inhibitor-induced apoptosis in lung cancers with oncoge- nic EGFRmutations 显示文摘	Costa DB Halmos B Kumar A	2007	Plos Med2007，4，10：	1
3	Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases显示文摘	Costa DB Shaw AT Ou SH	2015	J Clin Oncol2015，33，17：	1
4	BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations显示文摘	Costa DB Halmos B Kumar A		0，，10：	1
5	Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR - mutant non - small cell lung cancers 显示文摘	Costa DB	2007	Lung Cancer2007，5，：	1
6	Antibodies to Rickettsiarickettsii,Rickettsia typhi, Coxiella burnetii, Bartonella hens-elae ,Bartonella quintana, and Ehrlichia chaffeensis amonghealthy population in Minas Gerais,Brazil显示文摘	da Costa PS Brigatte ME Greco DB	2005	Mem Inst OswaldoCruz2005，100，8：	1
7	Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data显示文摘	Jorge SE Kobayashi SS Costa DB	2014	Braz J Med Biol Res2014，47，11：	1
8	BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with ancogenic EGFR mutations显示文摘	Costa DB Halmos B Kumar A	2007	PLoS Med2007，4，10：	1
9	Differential responses to erlotinib in epidermal growth factor receptor (EGFR)-muta- ted lung cancers with acquired resistance to gefitinib carrying the L747S or T790M secondary mutations显示文摘	Costa DB Schumer ST Tenen DG	2008	J Clin Oncol2008，26，：	1
10	Effects of eriotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib 显示文摘	Costa DB Nguyen KS Cho BC et o2	2008	Clin Cancer Res2008，14，：	1
11	Management and future directions in non-small cell lung cancer with known activating mutations 显示文摘	Gerber DE Gandhi L Costa DB	2014	Am Soc Clin Oncol Educ Book2014，34，：	1
12	BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations显示文摘	Costa DB Halmos B Kumar A	2007	PLoS Med2007，4，10：	1
13	Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastases 显示文摘	COSTA DB SHAW AT OU SH	2015	J Clin Oncol2015，33，17：	1
14	Acquired resist-ance to epidermal growth factor tyrosine kinase inhibi-tord in non-small-lung cancers dependent on epidermalgrowth factor receptor pathway显示文摘	Nquyen KS Kobayashi S Costa DB	2009	Clin Lung Canc-er2009，10，4：	1
15	Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers 显示文摘	Costa DB Kobayashi S Tenen DG	2007	Lung Cancer2007，58，1：	1
16	Prognostic versus predictive value of EML4-ALK translocation inmetastatic non-small cell lung cancer显示文摘	Shaw AT Yeap B Costa DB	2010	J Clin Oncol2010，28，15：	1
17	Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway显示文摘	Nguyen KS Kobayashi S Costa DB		0，，04：	1
18	A cquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer dependent on the epidermal growth factor receptor pathway显示文摘	Ngugen KS Kobayashis JH Costa DB	2009	Clin Lung Cancer2009，10，4：	1
19	Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR- mutant non-small cell lung cancers显示文摘	Costa DB Kobayashi S Tenen DG	2007	Lung Cancer2007，58，1：	1
20	Acquired Re- sistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non - Small - Cell Lung Cancers De- pendent on the Epidermal Growth Factor Receptor Path- way显示文摘	Nguyen KH Kobayashi S Costa DB	2009	Clinical lung cancer2009，10，4：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示